Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

 Razadyne (Galantamine Hydrobromide) ER (Formerly Reminyl)
Company:  Johnson & Johnson Pharmaceutical Research
Application No.:  021615
Approval Date: 12/22/2004

 

Date created: December 052005

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-